In addition, Li et al. found that SMYD2 was significantly upregulated in GBM stem cells, that loss of function of SMYD2 decreased GBM cell proliferation, and that in in vivo assays, loss of SMYD2 stopped tumor growth. The gene discussed is SMYD2; the disease is neoplasm.